Insilico Medicine("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, recently announced that its breakthrough drug candidate for idiopathic pulmonary ...

Trelleborg Medical is staking its claim to the biopharmaceutical and medical componentry space, boasting its time-to-market ...

Forskningsbolaget Diamyd Medical redovisar ett rörelseresultat på -42,3 miljoner kronor (-38,7) för det fjärde kvartalet i det brutna räkenskapsåret 2023/2024 (juni-augusti). Diamyd går vidare med ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate "safe and helpful answers" to questions posed by healthcare professionals ...

Lie on your back on a mat, and hold a single dumbbell (or medicine ball) with both of your hands. Lift your head, neck, and shoulders off the ground, and hold the dumbbell above your head with ...

Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma – a rare and often devastating ...

Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...

AllianceBernstein L.P. ("AB") and AllianceBernstein Holding L.P. ("AB Holding") (NYSE: AB) today announced that preliminary assets under management increased to $809 billion during January 2025 ...

Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...

Although customization is a popular initiative among the competition, AB is already one of the largest providers of custom target-date funds in the US, and its capabilities in managing and ...